Breaking News Instant updates and real-time market news.

FLKS

Flex Pharma

$11.20

-0.41 (-3.53%)

15:24
10/13/16
10/13
15:24
10/13/16
15:24

Flex Pharma explanations for trial setbacks 'quite sound,' says Piper Jaffray

Piper Jaffray analyst Joshua Schimmer noted that Flex Pharma has run into to some setbacks with its nocturnal leg cramping program, but he said the explanations provided by the company for the issues are "quite sound" in his opinion. Schimmer believes the totality of the data support FLKS-787 as a potential therapeutic for nocturnal leg cramps and possibly other disorders, he tells investors. The analyst keeps an Overweight rating and $25 price target on Flex Pharma shares, which are down 22% to $8.70 in afternoon trading.

  • 13

    Oct

  • 29

    Nov

FLKS Flex Pharma
$11.20

-0.41 (-3.53%)

12/17/15
PIPR
12/17/15
NO CHANGE
PIPR
Alexion buyout among Piper's potential Biopharma surprises in 2016
Piper Jaffray's Biopharma team, led by analyst Joshua Schimmer, announced their top potential surprise events for the sector in 2016. Schimmer's potential outcomes in 2016 include Gilead (GILD) buying Alexion (ALXN), Akorn (AKRX) being delisted by the Nasdaq, Shire (SHPG) reaching a deal to acquire Baxalta (BXLT), the Allergan (AGN), Pfizer (PFE) merger closing, NBA superstar LeBron James starting to drink Flex Pharma's (FLKS) "It's The Nerve" sports beverage, and Valeant (VRX) splitting itself up. Schimmer admits some of the predictions are low-probability events. Other potential outcomes making the list include four Duchenne muscular dystrophy drugs gaining FDA approval, followed by TheStreet's Adam Feuerstein offering a retraction, concerns over drug pricing abating, and Sangamo's (SGM) HIV program proven to be a "black swan."
04/11/16
ROTH
04/11/16
NO CHANGE
Target $24
ROTH
Buy
Roth Capital remains positive on Flex Pharma after 'encouraging' data
Roth Capital analyst Joseph Pantginis remains positive on Flex Pharma, following data from a second model of muscle cramping. The data showed statistically significant reductions in muscle cramping as well as positive impacts on muscle soreness, Pantginis tells investors in a research note, adding that he is now looking to visibility out of the soft launch of the consumer product this quarter. The analyst's projections for success remain unchanged, but he is taking a more conservative approach to his revenue projections as the "cult" brand is built. Pantginis reiterates a Buy rating and lowered his price target on the shares to $24 from $27.

TODAY'S FREE FLY STORIES

DVN

Devon Energy

09:12
01/23/18
01/23
09:12
01/23/18
09:12
Recommendations
Devon Energy analyst commentary  »

Devon Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TWTR

Twitter

09:12
01/23/18
01/23
09:12
01/23/18
09:12
Technical Analysis
Technical Take: Twitter drops on departure of COO Anthony Noto »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

CLR

Continental Resources

09:11
01/23/18
01/23
09:11
01/23/18
09:11
Recommendations
Continental Resources analyst commentary  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:10
01/23/18
01/23
09:10
01/23/18
09:10
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXO

Concho Resources

$160.41

4.22 (2.70%)

09:10
01/23/18
01/23
09:10
01/23/18
09:10
Recommendations
Concho Resources analyst commentary  »

Concho Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:09
01/23/18
01/23
09:09
01/23/18
09:09
Technical Analysis
Technical Take: Verizon trades higher after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

ANAB

AnaptysBio

$114.78

-0.135 (-0.12%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Recommendations
AnaptysBio analyst commentary  »

AnaptysBio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEC

Cimarex Energy

$126.80

2.76 (2.23%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Recommendations
Cimarex Energy analyst commentary  »

Cimarex Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    Feb

DGX

Quest Diagnostics

$103.57

0.51 (0.49%)

09:08
01/23/18
01/23
09:08
01/23/18
09:08
Hot Stocks
Quest Diagnostics to acquire MedXM for undisclosed amount »

Quest Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:07
01/23/18
01/23
09:07
01/23/18
09:07
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon says FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

SLB

Schlumberger

$79.79

3.37 (4.41%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$60.72

2.52 (4.33%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Recommendations
Anadarko analyst commentary  »

Anadarko price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

09:06
01/23/18
01/23
09:06
01/23/18
09:06
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon says 5G trials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

TWTR

Twitter

$23.32

-0.34 (-1.44%)

09:05
01/23/18
01/23
09:05
01/23/18
09:05
Hot Stocks
SoFi names former Twitter COO Anthony Noto as CEO »

SoFi announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

HAL

Halliburton

$56.40

3.39 (6.40%)

09:05
01/23/18
01/23
09:05
01/23/18
09:05
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.89

0.82 (0.90%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Hot Stocks
Procter & Gamble sees stronger earnings growth in Q4 than Q3 »

Views tax act as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

WPP

WPP

$95.32

-0.21 (-0.22%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Downgrade
WPP rating change  »

WPP downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.94

0.23 (0.36%)

, CHTR

Charter

$370.25

4.2 (1.15%)

09:03
01/23/18
01/23
09:03
01/23/18
09:03
Hot Stocks
T-Mobile closes Layer3 TV acquisition, prepares to take on cable, satellite TV »

T-Mobile US (TMUS)…

TMUS

T-Mobile

$63.94

0.23 (0.36%)

CHTR

Charter

$370.25

4.2 (1.15%)

CMCSA

Comcast

$42.89

0.39 (0.92%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 02

    Feb

TSLA

Tesla

$351.56

1.54 (0.44%)

09:03
01/23/18
01/23
09:03
01/23/18
09:03
Periodicals
Tesla CEO sees path to trillion-dollar company within 10 years »

"I actually see the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABC

AmerisourceBergen

$102.66

2.6 (2.60%)

09:02
01/23/18
01/23
09:02
01/23/18
09:02
Recommendations
AmerisourceBergen analyst commentary  »

AmerisourceBergen price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

XPER

Xperi

$22.50

-0.25 (-1.10%)

09:01
01/23/18
01/23
09:01
01/23/18
09:01
Hot Stocks
Xperi partners with ARCloud to bring music recognition to hybrid ratio »

Xperi Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
01/23/18
01/23
09:00
01/23/18
09:00
General news
U.S. equities are relatively subdued »

U.S. equities are…

FQVLF

First Quantum Minerals

$15.30

-0.01 (-0.07%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Downgrade
First Quantum Minerals rating change  »

First Quantum Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.46

1.55 (2.99%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Hot Stocks
Verizon says not considering large media acquisition »

Says remaining a partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

SANM

Sanmina

$27.08

-8.35 (-23.57%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Recommendations
Sanmina analyst commentary  »

Sanmina price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.